| 刘曼琪,崔 翔,蔡 玥,等.肝胆系统癌症所致健康寿命损失研究进展及对防控策略的启示[J].中国肿瘤,2025,34(12):979-986. |
| 肝胆系统癌症所致健康寿命损失研究进展及对防控策略的启示 |
| Loss of Healthy Life Expectancy Due to Hepatobiliary Cancers： Research Progress and Implications for Intervention Strategies |
| 投稿时间：2025-07-31 |
| DOI：10.11735/j.issn.1004-0242.2025.12.A010 |
|
 |
| 中文关键词: 肝胆系统癌症 健康预期寿命 干预措施 癌症 疾病负担 |
| 英文关键词:hepatobiliary cancers healthy life expectancy intervention cancer burden of disease |
| 基金项目:国家重点研发计划（2022YFC3600800） |
|
| 摘要点击次数: 32 |
| 全文下载次数: 0 |
| 中文摘要: |
| 摘 要：我国肝胆系统癌症疾病负担沉重且预后极差。2022年我国因该类疾病死亡人数占所有癌症的8.3%，5年生存率低于18%。研究肝胆系统癌症所致健康预期寿命损失不仅能够反映癌症人群的生存质量，也能为评估癌症负担及干预策略实施效果提供重要参考。全文就肝胆系统癌症疾病负担及其所致健康预期寿命损失的相关指标计算方法及应用进展做简要综述。 |
| 英文摘要: |
| Abstract： Hepatobiliary cancers pose a substantial disease burden in China and are associated with a poor prognosis， accounting for 8.3% of all cancer deaths in 2022， with a five-year survival rate below 18%. Assessing the loss of healthy life expectancy (HLE) due to these cancers provides a comprehensive measure of their burden and a valuable metric for evaluating the effectiveness of cancer control strategies. This paper reviews the methodologies and recent advances in indicators used to quantify the disease burden and HLE loss attributable to hepatobiliary cancers. |
|
在线阅读
查看全文 查看/发表评论 下载PDF阅读器 |